 HOUSTON and VANCOUVER, BC, Feb. 25, 2021 PRNewswire - ESSA Pharma Inc. ESSA or the Company NASDAQ: EPIX TSX-V: EPI, a clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, is pleased to announce the results of the... 